Q3 2020

Filed Nov 16, 2020 · 10-Q · 47 days after period end · 0001213900-20-037276

Q3 2020 · 10-Q

Revenue

$38.61M

no prior Q3 2019 on file

Net Income

-$56.62M

no prior Q3 2019 on file

EPS Diluted

-$456,573.00

no prior Q3 2019 on file

Gross Profit$4,586,000—

Operating Income

Same quarter

no prior Q3 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Sep 30, 2020 · filed Nov 16, 2020 · 47 d after period end

GeneDx Holdings Corp. · CIK 1818331 · Engraved from SEC EDGAR